在PFKP和c-Myc之间有一个积极的反循环,驱动头部和部状细胞癌的进展
Weiwei Liu1, Zhao Ding1, Ye Tao1
1Department of Otolaryngology, Head & Neck Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Molecular cancer
|July 9, 2024
概括
酸果酶-血小板 (PFKP) 通过稳定c-Myc.驱动头癌. 针对PFKP和c-Myc,为HNSCC患者提供了一个有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 异常的果酸酶-血小板 (PFKP) 表达与各种癌症有关.
- PFKP在头部和部状细胞癌 (HNSCC) 的特定作用和机制尚不清楚.
研究的目的:
- 阐明PFKP在HNSCC进展中的分子机制.
- 调查针对HNSCC的PFKP和c-Myc的治疗潜力.
主要方法:
- 在120个HNSCC患者组织中评估PFKP和c-Myc表达.
- 进行了体外和体内实验,以探索PFKP-c-Myc反循环.
- 利用患者衍生器官 (PDO) 和异种移植来评估治疗策略.
主要成果:
- 在HNSCC中,PFKP是上调调的,与预后不佳相关.
- 升高的PFKP通过ERK介导的c-Myc稳定促进HNSCC的扩散,血管生成和转移.
- 一个积极的反循环存在于c-Myc转录上调PFKP的地方.
- 同时准PFKP和c-Myc在临床前模型中显示出协同作用的抗瘤效应.
结论:
- PFKP/c-Myc反循环对于HNSCC的进展至关重要.
- 同时准PFKP和c-Myc是HNSCC的一种新且有效的治疗方法.
相关概念视频
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Positive Regulator Molecules
5.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.4K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


